The latest price target for Cassava Sciences (NASDAQ:SAVA) was reported by HC Wainwright & Co. on November 26, 2024. The analyst firm set a price target for $116.00 expecting SAVA to rise to within 12 months (a possible 4577.42% upside). 10 analyst firms have reported ratings in the last year.

The latest analyst rating for Cassava Sciences (NASDAQ:SAVA) was provided by HC Wainwright & Co., and Cassava Sciences downgraded their neutral rating.

The last upgrade for Cassava Sciences Inc happened on October 8, 2024 when HC Wainwright & Co. raised their price target to $116. HC Wainwright & Co. previously had a neutral for Cassava Sciences Inc.

The last downgrade for Cassava Sciences Inc happened on November 26, 2024 when HC Wainwright & Co. changed their price target from N/A to $116 for Cassava Sciences Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cassava Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cassava Sciences was filed on November 26, 2024 so you should expect the next rating to be made available sometime around November 26, 2025.

While ratings are subjective and will change, the latest Cassava Sciences (SAVA) rating was a downgraded with a price target of $0.00 to $116.00. The current price Cassava Sciences (SAVA) is trading at is $2.48, which is within the analyst’s predicted range.